Growth Metrics

Jazz Pharmaceuticals (JAZZ) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -14.40%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -9.89%
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -0.31%
10 Jazz Pharmaceuticals 14.64 Bn 12.79 Bn 934.80 Mn -3.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.72%
Dec 31, 2025 -4.30%
Sep 30, 2025 -4.42%
Jun 30, 2025 -8.25%
Mar 31, 2025 -11.45%
Dec 31, 2024 -12.27%
Sep 30, 2024 -11.56%
Jun 30, 2024 -15.15%
Mar 31, 2024 10.30%
Dec 31, 2023 9.86%
Sep 30, 2023 20.17%
Jun 30, 2023 21.36%
Mar 31, 2023 20.65%
Dec 31, 2022 20.14%
Sep 30, 2022 18.66%
Jun 30, 2022 23.49%
Mar 31, 2022 31.61%
Dec 31, 2021 8.63%
Sep 30, 2021 8.79%
Jun 30, 2021 13.78%
Mar 31, 2021 -11.54%
Dec 31, 2020 -9.06%
Sep 30, 2020 -7.00%
Jun 30, 2020 -2.08%
Mar 31, 2020 2.61%
Dec 31, 2019 6.95%
Sep 30, 2019 9.03%
Jun 30, 2019 10.81%
Mar 31, 2019 9.20%
Dec 31, 2018 32.79%
Sep 30, 2018 33.39%
Jun 30, 2018 32.73%
Mar 31, 2018 35.90%
Dec 31, 2017 42.84%
Sep 30, 2017 53.34%
Jun 30, 2017 52.58%
Mar 31, 2017 58.62%
Dec 31, 2016 96.14%
Sep 30, 2016 102.33%
Jun 30, 2016 105.52%
Mar 31, 2016 123.30%
Dec 31, 2015 127.36%
Sep 30, 2015 132.14%
Jun 30, 2015 158.97%
Mar 31, 2015 227.68%
Dec 31, 2014 234.67%
Sep 30, 2014 262.24%
Jun 30, 2014 290.28%
Dec 31, 2013 174.34%